Pipobromanum [Inn-Latin] en es it fr

Pipobromanum [Inn-Latin] Brand names, Pipobromanum [Inn-Latin] Analogs

Pipobromanum [Inn-Latin] Brand Names Mixture

  • No information avaliable

Pipobromanum [Inn-Latin] Chemical_Formula


Pipobromanum [Inn-Latin] RX_link

No information avaliable

Pipobromanum [Inn-Latin] fda sheet

Pipobromanum [Inn-Latin] msds (material safety sheet)

Pipobromanum [Inn-Latin] Synthesis Reference

No information avaliable

Pipobromanum [Inn-Latin] Molecular Weight

356.054 g/mol

Pipobromanum [Inn-Latin] Melting Point

> 300 oC

Pipobromanum [Inn-Latin] H2O Solubility

2490 mg/L

Pipobromanum [Inn-Latin] State


Pipobromanum [Inn-Latin] LogP


Pipobromanum [Inn-Latin] Dosage Forms

Tablet (25 mg)

Pipobromanum [Inn-Latin] Indication

For the treatment of polycythaemia vera and refractory chronic myeloid leukaemia.

Pipobromanum [Inn-Latin] Pharmacology

Pipobroman is an antineoplastic agent. Specifically it is a piperazine derivative with a chemical structure close to that of many DNA alkylating agents. Pipobroman has well documented clinical activity against polycythemia vera and essential thrombocythemia.

Pipobromanum [Inn-Latin] Absorption

Well absorbed from the GI tract.

Pipobromanum [Inn-Latin] side effects and Toxicity

Symptoms of overdose include hematologic toxicity, especially with chronic overdosage.

Pipobromanum [Inn-Latin] Patient Information

No information avaliable

Pipobromanum [Inn-Latin] Organisms Affected

Humans and other mammals